LeafNLP Demos
Back to explore

Report #2886713

Received Mar 19, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
1.2 yrs
State
TX
Recovered
Unknown
Vaccinated
Feb 13, 2026
Onset
Feb 13, 2026
Days to onset
0
Hospital days
—

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
MMRMEASLES + MUMPS + RUBELLA (PRIORIX)GLAXOSMITHKLINE BIOLOGICALS158160-831-03IM / LL
VARCELVARICELLA (VARIVAX)MERCK & CO. INC.UNKZ015167—

Symptoms (2)

Product preparation errorNo adverse event

Symptom narrative

No additional AE; Nurse called reporting an AE for VARIVAX. Caller reported that on 2/13/2026, a patient was inadvertently administered VARIVAX that was reconstituted with GSK SHINGRIX DILUENT.; This spontaneous report was received from a nurse and refers to a 1-year-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 13-Feb-2026, the patient was vaccinated with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), (valid lot #Z015167, expiration date: 29-Sep-2027) 0.5 mL administered by "INJ" route as prophylaxis, which was inadvertently reconstituted with sodium chloride (reported as GSK SHINGRIX DILUENT) (lot #947FS, expiration date: 18-Oct-2029) (product preparation error). No additional adverse event (AE) was reported.

Other medications

GSK DILUENT